Treatment of myelomatosis--M.R.C. trial.
作者信息
Galton D A
出版信息
Br Med J. 1971 May 8;2(5757):323-4. doi: 10.1136/bmj.2.5757.323.
Abstract
摘要
相似文献
1
Treatment of myelomatosis--M.R.C. trial.骨髓瘤治疗——医学研究委员会试验
Br Med J. 1971 May 8;2(5757):323-4. doi: 10.1136/bmj.2.5757.323.
2
Cyclophosphamide vs melphalan in treatment of plasma cell myeloma.环磷酰胺与美法仑治疗浆细胞骨髓瘤的对比
JAMA. 1969 Feb 17;207(7):1328-34.
3
Immunochemical classes of myelomatosis. Including data from a therapeutic trial conducted by a Medical Research Council working party.骨髓瘤的免疫化学分类。包括医学研究委员会一个工作组进行的一项治疗试验的数据。
Br J Haematol. 1969 Jun;16(6):599-606. doi: 10.1111/j.1365-2141.1969.tb00440.x.
4
Report on the first myelomatosis trial. I. Analysis of presenting features of prognostic importance.首例骨髓瘤试验报告。I. 对具有预后重要性的呈现特征的分析。
Br J Haematol. 1973 Jan;24(1):123-39.
5
[Comparative study of the melphalan and of the cyclophosphamide in the treatment of Kahler's disease].[美法仑与环磷酰胺治疗卡勒氏病的对比研究]
Therapeutique. 1971 Jan;47(1):27-32.
6
Multiple myeloma without initial paraproteins.无初始副蛋白的多发性骨髓瘤
Am J Med Sci. 1972 Oct;264(4):267-75. doi: 10.1097/00000441-197210000-00002.
7
Management of multiple myeloma.多发性骨髓瘤的管理
Br Med J. 1969 Apr 19;2(5650):163-5. doi: 10.1136/bmj.2.5650.163.
8
Plasmacytic myeloma. A study of the relationship of survival to various clinical manifestations and anomalous protein type in 112 patients.浆细胞骨髓瘤。112例患者生存与各种临床表现及异常蛋白类型关系的研究。
Am J Med. 1967 Jun;42(6):937-48. doi: 10.1016/0002-9343(67)90074-5.
9
Chronic hemodialysis in myelomatosis.骨髓瘤病中的慢性血液透析
Ann Intern Med. 1972 Aug;77(2):239-42. doi: 10.7326/0003-4819-77-2-239.
10
[Myeloma : symptoms, diagnosis, treatment].[骨髓瘤：症状、诊断、治疗]
Rev Prat. 1979 Jan 11;29(3):333-6, 339-44, 347-8.
引用本文的文献
1
2
Dialysis treatment in multiple myeloma.
Int Urol Nephrol. 1985;17(4):373-7. doi: 10.1007/BF02083508.
Zotero 插件